Please login to the form below

Zogenix

This page shows the latest Zogenix news and features for those working in and with pharma, biotech and healthcare.

Purdue gets FDA nod for abuse-deterrent painkiller

The new product will compete in the marketplace against products such as Zogenix' 12-hour Zohydro ER (hydrocodone), another long-acting opioid analgesic which was approved by the FDA last year ... Zogenix filed for approval of a line extension based on

Latest news

Dancing with the Deval

One critic (among many) was Massachusetts state governor Deval Patrick, who announced he was banning Zohydro from his state until its maker Zogenix developed an abuse-deterrent version.
FDA releases guidance on how to prevent abuse of opioid painkillers

The guidance comes one month after an FDA advisory committee voted against the approval of opioid-containing Zohydro from Zogenix due in part to its potential for abuse. ... Zogenix is currently working on an abuse-deterrent formulation of its drug.
Migraine drugs' headache

Injectable therapies are invasive and difficult to administer, while other therapies that exist, such as Zogenix's Sumavel DosePro needleless, are considered painful and can result in bruising.
Dermatology developments

Phase II. 130. Durect/Zogenix. Licenses long acting injectable risperidone to combine with Zogenix needle-free system.
Next generation

China . Sumatriptan needle-free injection . Sumavel DosePro (Zogenix, Astellas Pharma). Migraine, cluster headache.

More from news
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest Intelligence

Medius Deal Watch table for March 2015

456+. Zogenix / Pernix. Acquisition product. US marketed hydrocodone (Zohydro ER) for treatment of pain.
Pharma deals in March 2015

Zogenix (product). Pernix. 0.4. 33 / 9. NR. Cellular Dynamics. Fujifilm.
Deal Watch table for October 2014

145. Brabant Pharma/Zogenix. Acquisition. Includes fenfluramine for orphan I indication of Dravet syndrome.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

Zogenix appoints Pfizer’s R Scott Shively as chief commercial officer

Pain specialist Zogenix has appointed former Pfizer VP R Scott Shively as its new chief commercial officer. ... It's an exciting time to join and to make a contribution to the ongoing success of Zogenix.".

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest from PMHub

Welcoming analytics-driven digital marketing agency closerlook to the Fishawack Health pack

The company works with a range of innovative biopharma companies including UCB, Novo Nordisk, Astellas, Akebia, TerSera Therapeutics, Zogenix, BioMarin, and argenx.
Evoke Mind+Matter

Barrett, HealthforAnimals, Lloyds Pharmacy, Novo Nordisk, Raisio, Roche Diagnostics, Sanofi, Seqirus, SLG, Spark Therapeutics, Superdrug, Thornton &Ross, Vetoquinol, VMIC, Zogenix.